Advertisement · 728 × 90
#
Hashtag
#behçet
Advertisement · 728 × 90
Preview
Early Immunosuppression Reverses Severe Behçet-like Disease in Trisomy 8 MDS This case highlights the importance of early recognition of autoimmune gastrointestinal involvement in MDS.

Severe #Behçet-like intestinal disease associated with trisomy 8 #MDS can follow an aggressive, refractory course, but timely immune-targeted therapy may achieve both clinical and hematologic recovery even after repeated surgical complications.

Read here: https://bit.ly/3NMUjqD

0 0 0 0
Post image

🆕 Nouvelle web conférence exceptionnelle des jeudis de la filière !

✅ Nous vous retrouvons de nouveau en ce mois de décembre pour une toute nouvelle web conférence des jeudis de la filière sur le syndrome Behçet en 2025.

🔗 Pour la visionner : www.fai2r.org/videotheque-...

#santé #fai2r #Behçet

0 0 0 0

Whenever you see a young male with EN and DVT, always remember to ask about oral&genital ulcers!

#VTE #thrombosis #Behçet #IMSky

0 0 0 0
How (Ultra‐)Rare Gene Variants Improve Our Understanding of More Common Autoimmune and Inflammatory Diseases The aim of this study was to explore the impact of rare and ultra-rare genetic variants on the understanding and treatment of autoimmune and autoinflammatory diseases with a focus on systemic lupus e...

How (Ultra-)Rare Gene Variants Improve Our Understanding of More Common Autoimmune and Inflammatory Diseases

#SLE #Behçet #MonigenicLupus #Lupus

acrjournals.onlinelibrary.wiley.com/doi/10.1002/...

3 0 0 0
Preview
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome Cyclophosphamide and infliximab are recommended as induction therapies for severe Behçet’s syndrome. Whether infliximab is safer and more effective than cyclophosphamide in treating severe Behçet’s...

📌Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome

Induction therapy with #infliximab had a superior complete response rate at 22 weeks and fewer adverse events than induction with #cyclophosphamide

#behçet @nejm.org

evidence.nejm.org/doi/full/10....

1 1 0 0